Quarterly report pursuant to Section 13 or 15(d)

Intangible Assets (Narrative) (Details)

v3.22.1
Intangible Assets (Narrative) (Details) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Aug. 23, 2021
Finite-Lived Intangible Assets [Line Items]          
Impairment of intangible assets     $ 0 $ 0  
Amortization of Intangible Assets $ 122,000 $ 73,000 $ 333,000 $ 218,000  
Patents and Licenses [Member]          
Finite-Lived Intangible Assets [Line Items]          
Intangible asset, useful life     10 years    
Maximum [Member] | Intellectual Property [Member]          
Finite-Lived Intangible Assets [Line Items]          
Intangible asset, useful life     23 years    
Minimum [Member] | Intellectual Property [Member]          
Finite-Lived Intangible Assets [Line Items]          
Intangible asset, useful life     16 years    
RubrYc Theraputics, Inc. [Member] | Immune-Oncology Antibodies (RTX-003) [Member]          
Finite-Lived Intangible Assets [Line Items]          
Investment         $ 7,500,000